With diabetes being a complex health condition, finding a cure for it naturally comes with quite a few challenges. However, scientists have recently made a huge breakthrough regarding the search for a cure by purging mice of the debilitating illness. This puts them one step closer to finally ending the suffering of thousands around the world who are living with diabetes every day.
Now, it’s worth noting that the study is still in its very early stages and there is still a lot of work to be done. However, it is encouraging to know that UT Health San Antonio researchers finally found a way to improve insulin secretion, which could potentially end insulin-dependency by diabetics, Futurism reports.
The researchers have tested their new method on lab mice that were afflicted with the disease and the rodents were cured. For one year, the subjects exhibited no symptoms to indicate that the cure did not work. Dr. Bruno Doiron, one of the researchers behind the project said as much.
“It worked perfectly,” Dr. Doiron said. “We cured mice for one year without any side effects. That’s never been seen. But it’s a mouse model, so caution is needed. We want to bring this to large animals that are closer to humans in physiology of the endocrine system.”
As a result, the researchers are now thinking about moving the cure to human trials over the next three years. That might seem like a lifetime, but it’s much closer than anyone has ever been to rid the world of diabetes.
It would seem that the obstacles won’t be much of an issue either since it would appear that the Food and Drug Administration has granted approval to similar cases in the past, News.com.au reports. If so, the world should be on track to becoming free of diabetes in the next decade or so.


China vs. NASA: The New Moon Race and What's at Stake by 2030
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
Tabletop particle accelerator could transform medicine and materials science
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
FDA Weighs Safety Standards for Psychedelic Therapies
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
France Keeps Top Health Alert as Officials Brace for Another Heatwave
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children 



